Marc Beer is the CEO, chairman, and co-founder of Renovia Inc. which was established in August 2016. The Company is involved in developing numerous diagnostic and relaxing products to treat pelvic base disorders like urinary incontinence which approximately affects 250 million women globally. Marc was a graduate of Miami University in Ohio. He happens to possess more than 25 years’ experience as a manager in the pharmaceutical, biotechnology, diagnostic and device industries. A good example is OvaScience Company where he worked as a strategic consultant. Despite being such a busy man, he always makes time for his wife and three children. Speaking of Renovia, They have a new product called Leva which was sanctioned in April the previous year. Marc says that he developed the idea of taking the initiative to look for a solution for pelvic floor disorder from a gynecologist called Dr. Ray Iglesias. Marc is also the founding chairman of the directors’ board, the compensation committee, chairman to the Good Start Genetics Compensation committee (GSGCC) plus a member of Minerva Neurosciences INC Audit committee –MNIAC and also a Business Advisory Council –BAC of Miami University.
The Longwood Fund, an investment firm dedicated to health care joined hands with Renovia to advance and test four more therapeutic and diagnostic products including a new cohort of the Leva device. Marc beer Renovia’s CEO commented that “combining our innovative and proprietary sensor technologies and form factors with a digital health platform will give our customers valuable data to inform new treatment options, drive greater knowledge and understanding of pelvic floor disorders and ultimately lower long-term healthcare costs. Recently, it raised $42 million to improve the health of Boston Women. The money will go to product development pipeline and future business launches. Funding in Renovia mostly occurred in its Series A whereby the technology was got from another company. The series B is where Longwood re-instated into Renovia which was led by Ascension Ventures of Missouri and perceptive advisors of New York. It is important to note that the pelvic training product is designed to help women in performing strengthening exercises which is essential. This project will surely save a lot of lives. Learn more: https://www.businesswire.com/news/home/20180821005199/en/Renovia-Completes-42.3-Million-Series-Financing